Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07413211 · ClinicalTrials.gov registry record

Genetic Developmental and Epileptic Encephalopathy Natural History Study for Clinical Trial Readiness

A clinical trial of MEF2C and DEE, sponsored by Weill Medical College of Cornell University.

Recruiting
Registry status
22,068
Enrollment target
1
Study location

NCT07413211 is a study of MEF2C and DEE that is actively recruiting participants, run by Weill Medical College of Cornell University. The registered enrollment target is 22,068 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07413211, a study of MEF2C and DEE, is actively recruiting participants, sponsored by Weill Medical College of Cornell University.

RECRUITING
Registry status
22,068 participants
Enrollment target
1
Study location

Study Summary

Phase 0 non-interventional longitudinal study of children and adults with Developmental and Epileptic Encephalopathy (DEE) due to a genetic cause. There are six arms of the study. Arms 1, 2, and 3 are devoted to one example DEE, MEF2C Haploinsufficiency Syndrome (MCHS). Arms 4, 5, and 6 are open to all DEE. Arm 1 (in-person) will enroll children 0 to 15, who will make in-person visits to Weill Cornell Medicine four times over two years. Arm 2 (virtual) will enroll people of all ages and older who will make virtual visits over Weill Cornell Zoom to Weill Cornell Medicine over two years (2 if 16 and older; 4 if 0 to 15). Arm 3 (registry) will enroll people of all ages in an online-only survey. Arms 4 - 6 mirror this structure but they are open to all children with DEE. Arm 4 (in-person) will enroll children of any age, who will make in-person visits every 6 months for 10 years. Arm 5 (virtual) will enroll children of any age for virtual visits, twice a year of 0 to 15, once a year if 16 or older. Arm 6 (registry) will enroll people of all ages in an online only survey.

Conditions Studied

Interventions

  • OTHER Observation

Study Locations (1)

New York

  • Weill Cornell Medicine - New York

Trial Details

FieldValue
Enrollment Target 22,068 participants
Start Date 2025-02-26
Est. Completion 2037-04-30

What the Registry Record Tells You About NCT07413211

The ClinicalTrials.gov registry entry for NCT07413211 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 22,068 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with MEF2C appearing as the primary indexed condition, and to 1 intervention - of which Observation is the first listed.

NCT07413211 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT07413211 about?

NCT07413211 is a clinical study titled "Genetic Developmental and Epileptic Encephalopathy Natural History Study for Clinical Trial Readiness". Phase 0 non-interventional longitudinal study of children and adults with Developmental and Epileptic Encephalopathy (DEE) due to a genetic cause. There are six arms of the study. Arms 1, 2, and 3 are devoted to one example DEE, MEF2C Haploinsufficiency Syndrome (MCHS). Arms 4, 5, and 6 are open to ...

What is the current status of trial NCT07413211?

This trial is currently recruiting. The enrollment target is 22,068 participants. The study started on 2025-02-26. Estimated completion is 2037-04-30.

What conditions does trial NCT07413211 study?

This clinical trial studies the following conditions: MEF2C, DEE.

What interventions are being tested in trial NCT07413211?

The interventions under investigation include: Observation (OTHER).

Who is sponsoring clinical trial NCT07413211?

This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07413211 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.